Torrent Pharma Q1 PAT up 21 pc at ₹457 crore

The drug maker had reported a profit after tax (PAT) of ₹378 crore in the April-June quarter of the last fiscal.

Revenue for the first quarter stood at ₹2,859 crore, as against ₹2,591 crore in the year-ago period, Torrent Pharma said in a statement.

The company said its India revenues rose 15% year-on-year to ₹1,635 crore in the June quarter, aided by robust performance in focus therapies.

Shares of the company on Tuesday ended 3.58% up at ₹3,137.15 apiece on the BSE.

Torrent Pharma’s current market capitalization stands at ₹1,06,258 crore, it has a return on capital employed value (ROCE) of 23.2 % and a return on equity value (ROE) of 24.2 %.

The pharmaceutical company has a significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments, and has marked its presence in across 50 countries.